Varick Street

Contineum Therapeutics Announces Pricing of Initial Public Offering

Retrieved on:

Friday, April 5, 2024

Montgomery Street, Goldman Sachs, Vesey Street, Telephone, Inflammation, SAN, Sale, Attention, Security (finance), Prospectus, Morgan Stanley, Suite, Therapy, Varick Street, Equity capital markets, RBC Capital Markets

All of the shares are being offered by Contineum.

Key Points:

All of the shares are being offered by Contineum.
The gross proceeds to Contineum from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Contineum, are expected to be $110.0 million.
In addition, Contineum has granted the underwriters a 30-day option to purchase up to an additional 1,031,250 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions.
Goldman Sachs & Co. LLC, Morgan Stanley, Stifel, and RBC Capital Markets are acting as joint book-running managers for the offering.

Nasdaq Announces Pricing of Secondary Offering of Nasdaq Common Stock by Borse Dubai

Retrieved on:

Wednesday, March 20, 2024

Exercise, Borse Dubai, Goldman Sachs, Communication, Telephone, EDGAR, Sale, NDAQ, Prospectus, Morgan Stanley, Varick Street, 2nd Floor, Security (finance)

NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ or Nasdaq) today announced the pricing of the previously announced secondary offering by Borse Dubai of 26,956,522 shares of Nasdaq’s common stock at $59.00 per share.

Key Points:

NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ or Nasdaq) today announced the pricing of the previously announced secondary offering by Borse Dubai of 26,956,522 shares of Nasdaq’s common stock at $59.00 per share.
Borse Dubai has also granted the underwriters a 30-day option to purchase up to 4,043,478 additional shares of Nasdaq’s common stock.
Nasdaq is not offering any shares in the offering and will not receive any proceeds from the offering.
Borse Dubai will receive all of the proceeds from the offering.

Nasdaq and Borse Dubai Announce Launch of Secondary Offering of Nasdaq Common Stock

Retrieved on:

Tuesday, March 19, 2024

Exercise, Goldman Sachs, Borse Dubai, Communication, Telephone, EDGAR, Sale, NDAQ, Prospectus, Morgan Stanley, Varick Street, 2nd Floor, Security (finance)

NEW YORK and DUBAI, United Arab Emirates, March 19, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ or Nasdaq) and Borse Dubai Limited (Borse Dubai) today announced the commencement of a secondary offering by Borse Dubai of 26,956,522 shares of Nasdaq’s common stock.

Key Points:

NEW YORK and DUBAI, United Arab Emirates, March 19, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ or Nasdaq) and Borse Dubai Limited (Borse Dubai) today announced the commencement of a secondary offering by Borse Dubai of 26,956,522 shares of Nasdaq’s common stock.
Borse Dubai also expects to grant the underwriters a 30-day option to purchase up to 4,043,478 additional shares of Nasdaq’s common stock.
Nasdaq is not offering any shares in the offering and will not receive any proceeds from the offering.
At the completion of the offering, Borse Dubai is expected to be the second largest shareholder in Nasdaq.

ODDITY Announces Pricing of Secondary Offering of Class A Ordinary Shares

Retrieved on:

Friday, March 15, 2024

Telephone, Sale, Attention, Prospectus, Broadridge Financial Solutions, KeyBank, Varick Street, 2nd Floor, J.P. Morgan & Co., Security (finance)

NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) today announced the pricing of a previously announced underwritten secondary public offering of 4,782,609 of ODDITY’s Class A ordinary shares (“Ordinary Shares”) by a fund managed by L Catterton (the “Selling Stockholder”) at a price of $43.50 per share.

Key Points:

NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) today announced the pricing of a previously announced underwritten secondary public offering of 4,782,609 of ODDITY’s Class A ordinary shares (“Ordinary Shares”) by a fund managed by L Catterton (the “Selling Stockholder”) at a price of $43.50 per share.
The Selling Stockholder has also granted the underwriters a 30-day option to purchase up to an additional 717,391 Ordinary Shares.
The offering is expected to close on March 19, 2024, subject to the satisfaction of customary closing conditions.
ODDITY is not selling any Ordinary Shares in the offering and will not receive any proceeds from the sale of the shares being offered by the Selling Stockholder.

ODDITY Announces Secondary Offering of Class A Ordinary Shares

Retrieved on:

Tuesday, March 12, 2024

Exchange, Telephone, Sale, Attention, Security (finance), Prospectus, Broadridge Financial Solutions, Varick Street, 2nd Floor, Barclays, J.P. Morgan & Co.

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) today announced the commencement of an underwritten secondary public offering of 4,000,000 of ODDITY’s Class A ordinary shares (“Ordinary Shares”) by a fund managed by L Catterton (the “Selling Stockholder”).

Key Points:

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) today announced the commencement of an underwritten secondary public offering of 4,000,000 of ODDITY’s Class A ordinary shares (“Ordinary Shares”) by a fund managed by L Catterton (the “Selling Stockholder”).
The Selling Stockholder intends to grant the underwriters a 30-day option to purchase up to an additional 600,000 Ordinary Shares.
ODDITY is not selling any Ordinary Shares in the offering and will not receive any proceeds from the sale of the shares being offered by the Selling Stockholder.
Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Allen & Company LLC and Evercore Group L.L.C.

Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares

Retrieved on:

Tuesday, March 26, 2024

Stevanato Group sold 7,302,500 ordinary shares (the “Company Offering”), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the “Selling Shareholder”), sold 7,302,500 ordinary shares (the “Selling Shareholder Offering” and, together with the Company Offering, the “Offering”).

Key Points:

Stevanato Group sold 7,302,500 ordinary shares (the “Company Offering”), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the “Selling Shareholder”), sold 7,302,500 ordinary shares (the “Selling Shareholder Offering” and, together with the Company Offering, the “Offering”).
The total gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $379.7 million, or approximately $189.8 million from each of the Company Offering and the Selling Shareholder Offering.
Stevanato Group will not receive any proceeds from the Selling Shareholder Offering.
Morgan Stanley and William Blair served as lead book-running managers and as representatives of the underwriters for the Offering.

Auna Announces Pricing of Initial Public Offering of US$360 Million (Gross Proceeds) of Class A Shares

Retrieved on:

Friday, March 22, 2024

Managed Care, Hospitals, Health Insurance, Health, Citigroup, J. P. Morgan, Madison Avenue, Form, Telephone, Morgan Stanley, Sale, Lexington Avenue, Prospectus, BTG Pactual, HSBC, Varick Street, 2nd Floor, J.P. Morgan & Co., Security (finance)

Auna S.A. (“Auna”) a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it has priced its initial public offering of 30,000,000 class A ordinary shares (“class A shares”), at a price of US$12.00 per class A share.

Key Points:

Auna S.A. (“Auna”) a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it has priced its initial public offering of 30,000,000 class A ordinary shares (“class A shares”), at a price of US$12.00 per class A share.
The class A shares have been approved for listing on the New York Stock Exchange and will start trading on March 22, 2024 under the ticker symbol “AUNA”.
The offering is expected to settle on or about March 26, 2024, subject to customary closing conditions.
In connection with the offering, Auna has granted to the underwriters a 30-day option to purchase up to an additional 4,500,000 class A shares at the initial public offering price.

Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares

Retrieved on:

Friday, March 22, 2024

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the pricing of its upsized underwritten public offering of an aggregate of 12,700,000 of its ordinary shares at a public offering price of $26.00 per share.

Key Points:

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the pricing of its upsized underwritten public offering of an aggregate of 12,700,000 of its ordinary shares at a public offering price of $26.00 per share.
Stevanato Group is offering 6,350,000 ordinary shares (the “Company Offering”), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the “Selling Shareholder”), which currently holds approximately 78% of Stevanato Group’s outstanding ordinary shares, is offering 6,350,000 ordinary shares (the “Selling Shareholder Offering” and, together with the Company Offering, the “Offering”).
Stevanato Group and the Selling Shareholder have granted the underwriters an option, exercisable for 30 days after the date of the final prospectus supplement, to purchase up to 1,905,000 additional ordinary shares on the same terms and conditions.
Stevanato Group will not receive any proceeds from the Selling Shareholder Offering.

Reddit Announces Pricing of Initial Public Offering

Retrieved on:

Wednesday, March 20, 2024

Media, Communications, Social Media, Citigroup, BofA Securities, JMP, J. P. Morgan, Goldman Sachs, Telephone, Sale, Attention, Security (finance), Prospectus, Bank of America, Broadridge Financial Solutions, MUFG, Varick Street, Deutsche Bank

Reddit, Inc. (“Reddit”) today announced the pricing of its initial public offering of an aggregate 22,000,000 shares of its Class A common stock, 15,276,527 of which are being sold by Reddit and 6,723,473 of which are being sold by certain selling stockholders, at a public offering price of $34 per share.

Key Points:

Reddit, Inc. (“Reddit”) today announced the pricing of its initial public offering of an aggregate 22,000,000 shares of its Class A common stock, 15,276,527 of which are being sold by Reddit and 6,723,473 of which are being sold by certain selling stockholders, at a public offering price of $34 per share.
Reddit will not receive any proceeds from any sale of shares by the selling stockholders.
In addition, Reddit has granted the underwriters a 30-day option to purchase up to an additional 3,300,000 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions.
Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, J.P. Morgan, and BofA Securities are acting as lead book-running managers for the offering.

Stevanato Group Announces Public Offering of Ordinary Shares

Retrieved on:

Wednesday, March 20, 2024

Medical Supplies, Health, Medical Devices, Research, Science, Pharmaceutical, Biotechnology, Form, Telephone, Stevanato Group, William Blair & Company, Sale, Attention, Security (finance), Prospectus, Morgan Stanley, Varick Street, 2nd Floor

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the launch of an underwritten public offering of an aggregate of $300,000,000 of its ordinary shares.

Key Points:

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the launch of an underwritten public offering of an aggregate of $300,000,000 of its ordinary shares.
Stevanato Group is offering $150,000,000 of its ordinary shares (the “Company Offering”), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the “Selling Shareholder”), which currently holds approximately 78% of Stevanato Group’s outstanding ordinary shares, is offering $150,000,000 of its ordinary shares (the “Selling Shareholder Offering” and, together with the Company Offering, the “Offering”).
Stevanato Group and the Selling Shareholder also intend to grant the underwriters an option, exercisable for 30 days after the date of the final prospectus supplement, to purchase additional ordinary shares up to an amount equal to 15% of the aggregate number of ordinary shares offered in the Offering on the same terms and conditions.
Stevanato Group intends to use the net proceeds from the Company Offering for general corporate purposes, including to enable Stevanato Group to satisfy the requirements of its ongoing investment activities and working capital needs, and to ensure an appropriate level of operating and strategic flexibility.